Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

02.03.2026

2 Acta Neuropathol
19 Alzheimers Dement
1 Am J Geriatr Psychiatry
1 BMC Neurol
1 Brain
1 Brain Res
2 Curr Opin Neurol
1 Dement Geriatr Cogn Disord
11 J Alzheimers Dis
1 J Neurochem
1 J Neurol Neurosurg Psychiatry
3 Lancet Neurol
1 Nat Neurosci
2 Nature
1 Neurobiol Aging
1 Neurochem Res
1 Neuroscience
1 Rev Neurol (Paris)


    Acta Neuropathol

  1. LAROCHE VT, Cavill R, Kouhsar M, Muller J, et al
    Epigenomic subtypes of late-onset Alzheimer's disease reveal distinct microglial signatures.
    Acta Neuropathol. 2026;151:20.
    >> Share

  2. CHEN Y, La Joie R, Pereira FL, Blazhenets G, et al
    Disentangling on and off-target binding in flortaucipir PET: a voxel-to-voxel P-tau, ferric iron, and MAO-B histology-to-flortaucipir PET comparison.
    Acta Neuropathol. 2026;151:21.
    >> Share


    Alzheimers Dement

  3. WILLETT JDS, Waqas M, Naumenko S, Mullin K, et al
    Matching heterogeneous cohorts by projected principal components reveals two novel Alzheimer's disease-associated genes in the Hispanic population.
    Alzheimers Dement. 2026;22:e71189.
    >> Share

  4. MILA-ALOMA M, Hausle I, Myoraku A, Sorensen C, et al
    Sex differences in Alzheimer's disease plasma biomarker levels and clinical utility.
    Alzheimers Dement. 2026;22:e71244.
    >> Share

  5. HOSSEINI SA, Aumont E, Rahmouni N, Woo MS, et al
    Choroidal-ventricular system abnormalities are linked to amyloid-beta aggregation in Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71205.
    >> Share

  6. AJITH I, Bakshi S, Mead E, Gileadi O, et al
    Assessing Abeta-independent effects of Module 42 on immune function in vitro.
    Alzheimers Dement. 2026;22:e71215.
    >> Share


  7. Correction to "The dynamics of cognitive decline toward Alzheimer's disease progression: Results from ADSP-PHC's harmonized cognitive composites".
    Alzheimers Dement. 2026;22:e71246.
    >> Share

  8. YANG X, Li Y, Yao M, Bibic A, et al
    Vascular smooth muscle cell loss, but not neuroinflammation, drives cerebrovascular reactivity impairment in Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71209.
    >> Share

  9. AKINCI M, Aziz F, Guzman D, Cheung L, et al
    Association of type 2 diabetes treatment status with in vivo biomarkers of Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71214.
    >> Share

  10. TANG C, Yan J, Chen Y, Peng X, et al
    Waking up to the truth: Associations between sleep disorders and multidomain functional outcomes in Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71200.
    >> Share

  11. BLEDSOE X, Wang TC, Wu Y, Archer D, et al
    Neuroimaging PheWAS and molecular phenotyping implicate PSMC3 in Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71217.
    >> Share

  12. XICOTA L, Cheng R, Andersen SL, Zmuda JM, et al
    RBFOX1 association with age at onset of Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71188.
    >> Share

  13. KLINGER HM, Seto M, Janve VA, Brown JA, et al
    Whole blood gene expression moderates associations between AD biomarkers and cognitive decline in cognitively unimpaired older adults.
    Alzheimers Dement. 2026;22:e71225.
    >> Share

  14. CHEN C, Lee JH, Park KH, Hu CJ, et al
    Clinical meaningfulness of anti-amyloid therapies in early Alzheimer's disease: Perspectives from the East and Southeast Asia region.
    Alzheimers Dement. 2026;22:e71230.
    >> Share


  15. Correction to "The National Alzheimer's Coordinating Center (NACC) 1999-2025: Personal history and recollections".
    Alzheimers Dement. 2026;22:e71222.
    >> Share

  16. CARRILLO MC, Mahinrad S
    The partnership between the Alzheimer's Association, Alzheimer's Disease Research Centers (ADRCs), and the National Alzheimer's Coordinating Center (NACC) in advancing Alzheimer's disease research and care.
    Alzheimers Dement. 2026;22:e71210.
    >> Share

  17. CHIMAL-JUAREZ E, Jury-Garfe N, Gomez-Isaza L, Troncoso JC, et al
    Spatially resolved transcriptomic profiling identifies distinct signatures in parenchymal and vascular microenvironments in Alzheimer's Disease with Cerebral Amyloid Angiopathy.
    Alzheimers Dement. 2026;22:e71208.
    >> Share

  18. YANG X, Zhang J, Xie F, Wang Y, et al
    Perilesional white matter gradients reveal microstructural differences in cerebral amyloid angiopathy versus Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71182.
    >> Share

  19. ARIYATH A, Mputhia Z, Dougherty C, Rahuman BK, et al
    Regulation of autophagy-mediated pathways by diet, physical activity, and sleep in Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71191.
    >> Share

  20. YOU JC, Bender AC, Berezuk C, Noriega-Makarskyy DT, et al
    Long-term forgetting, sleep, and tau in autosomal-dominant Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71235.
    >> Share

  21. ORELLANA P, Caviedes A, Gonzalez L, Ochoa-Rosales C, et al
    Association of apolipoprotein E variants on Alzheimer's disease in Latin America: A systematic review and meta-analysis.
    Alzheimers Dement. 2026;22:e71224.
    >> Share


    Am J Geriatr Psychiatry

  22. SU X, Wang Y, Zhao B, Wang C, et al
    Resting-State Cerebral Blood Flow and Its Disconnect From Functional Connectivity in Alzheimer's Disease Spectrum.
    Am J Geriatr Psychiatry. 2026 Jan 31:S1064-7481(26)00038.
    >> Share


    BMC Neurol

  23. DUAN H, Ukraintseva S, Holmes R, Wu D, et al
    Towards personalized vaccine repurposing for Alzheimer's prevention: genotype-specific protective association of the shingles vaccine with odds of Alzheimer's disease in participants of two large cohort studies.
    BMC Neurol. 2026 Feb 25. doi: 10.1186/s12883-026-04728.
    >> Share


    Brain

  24. KALARIA RN
    The rise and rise of vascular dysfunction in Alzheimer's disease.
    Brain. 2026 Feb 25:awag076. doi: 10.1093.
    >> Share


    Brain Res

  25. MANASA M, Bethanagere Ramesha G, Krishna KL, Ambika MS, et al
    Harnessing estrogen's neuroprotective potential in mitigating Alzheimer's pathologies in postmenopausal women: a review.
    Brain Res. 2026;1879:150226.
    >> Share


    Curr Opin Neurol

  26. ZENG X, Nicholson N, Karikari TK
    Blood-based biomarkers of Alzheimer's disease: potential utility in clinical practice.
    Curr Opin Neurol. 2026 Feb 24. doi: 10.1097/WCO.0000000000001475.
    >> Share

  27. BLUMA M, Chiotis K, Nordberg A
    Integration over reduction: multimodal PET and fluid biomarkers in Alzheimer's disease and beyond.
    Curr Opin Neurol. 2026 Feb 24. doi: 10.1097/WCO.0000000000001462.
    >> Share


    Dement Geriatr Cogn Disord

  28. FLAVELL J, Ahern EGM, Logan B, Shaw TB, et al
    Differentiating behavioural presentations of biomarker-confirmed Alzheimer's disease from frontotemporal lobar degeneration using the Addenbrooke's Cognitive Examination-III.
    Dement Geriatr Cogn Disord. 2026 Feb 27:1-17. doi: 10.1159/000551258.
    >> Share


    J Alzheimers Dis

  29. NDIONUKA IB
    Alzheimer's disease and dementia care in Nigeria: Challenges, realities, and the call for a national strategy.
    J Alzheimers Dis. 2026 Feb 26:13872877261424254. doi: 10.1177/13872877261424254.
    >> Share

  30. NIXON AG, Hong NS, Agha BM, Ham JR, et al
    The effects of chronic cannabidiol administration on brain pathology and behavioral deficits found in the tau P301s-line PS19 mouse model of Alzheimer's disease.
    J Alzheimers Dis. 2026 Feb 24:13872877261421654. doi: 10.1177/13872877261421654.
    >> Share

  31. FUJISAWA C, Fujisawa H, Matsui Y, Sugimoto T, et al
    Activities of daily living, behavioral and psychological symptoms of dementia, and cognitive and physical function according to thyroid function in Alzheimer's disease.
    J Alzheimers Dis. 2026 Feb 24:13872877261424207. doi: 10.1177/13872877261424207.
    >> Share

  32. DELGADO-ALVAREZ A, Delgado-Alonso C, Valles-Salgado M, Gonzalez-Baz V, et al
    Diagnostic performance of the Mini-Mental State Examination and three cross-cultural screening tests in majority and diverse populations.
    J Alzheimers Dis. 2026;109:1615-1620.
    >> Share

  33. MANIPPA V
    Gamma sensory stimulation: Investigating human brain response to optimize clinical translation.
    J Alzheimers Dis. 2026;109:1628-1629.
    >> Share

  34. MARCOLINI S, Mondragon JD, van Roon AM, Tegegne BS, et al
    Limited evidence for heart rate variability as a predictor of cognitive and pathophysiological brain markers.
    J Alzheimers Dis. 2026;109:1723-1732.
    >> Share

  35. FUJITA K, Kaneda D, Sakurai K, Matsubara T, et al
    A gray matter volume network in pathologically confirmed cases of argyrophilic grain disease: An exploratory analysis.
    J Alzheimers Dis. 2026;109:1925-1930.
    >> Share

  36. ZHANG S, Xue G, Zhang M, Ding N, et al
    Research progress on the role of acupuncture in Alzheimer's disease based on the PI3K/AKT/mTOR signaling pathway.
    J Alzheimers Dis. 2026 Feb 22:13872877261418553. doi: 10.1177/13872877261418553.
    >> Share

  37. INAGAWA Y, Kamiya T, Miyagi Y, Inagawa S, et al
    Evaluation of the effects of lecanemab treatment on brain atrophy using voxel-based specific regional analysis system for Alzheimer's disease.
    J Alzheimers Dis. 2026 Feb 23:13872877261422452. doi: 10.1177/13872877261422452.
    >> Share

  38. HAKIM M, Ranjan R, Ken-Dror G, Yusuf MA, et al
    Next-generation sequencing study identifies the first genes associated with Alzheimer's disease in Bangladeshi population: The CARED study.
    J Alzheimers Dis. 2026 Feb 23:13872877261419066. doi: 10.1177/13872877261419066.
    >> Share

  39. ROMANO D, Tosi G
    Divergent network trajectories in mild cognitive impairment: Converters versus non-converters to Alzheimer's disease.
    J Alzheimers Dis. 2026 Feb 24:13872877261423962. doi: 10.1177/13872877261423962.
    >> Share


    J Neurochem

  40. GAO Z, Wang Y, Ren Y, Lyu J, et al
    Integrated Bioinformatics Analysis of Screen Mitochondrial Autophagy-Related Core Genes and Construct Diagnostic Model for Alzheimer's Disease.
    J Neurochem. 2026;170:e70387.
    >> Share


    J Neurol Neurosurg Psychiatry

  41. LIN YH, Hsu TW, Kao YC, Thompson T, et al
    Cumulative cognitive benefits and brain volume change with anti-amyloid therapies for Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2026 Feb 27:jnnp-2025-336691.
    >> Share


    Lancet Neurol

  42. THE LANCET NEUROLOGY
    Stopping Alzheimer's disease before symptoms start.
    Lancet Neurol. 2026;25:213.
    >> Share

  43. SCHNEIDER L
    When Alzheimer's disease prevention becomes policy: regulatory speed, commercialisation, and risk.
    Lancet Neurol. 2026;25:219-220.
    >> Share

  44. REIMAN EM, Alexander RC, Langbaum JB, Aisen PS, et al
    A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USA.
    Lancet Neurol. 2026;25:268-278.
    >> Share


    Nat Neurosci

  45. TIAN Y, Hornburg K, Austin W, Cook JJ, et al
    Magnetic resonance microscopy maps widespread effects of Alzheimer's disease on brain structures and behavior in mice.
    Nat Neurosci. 2026 Feb 26. doi: 10.1038/s41593-025-02199.
    >> Share


    Nature

  46. FIELDHOUSE R
    China is waging war on Alzheimer's. What can its approach teach the rest of the world?
    Nature. 2026;650:816-818.
    >> Share

  47. DISOUKY A, Sanborn MA, Sabitha KR, Mostafa MM, et al
    Human hippocampal neurogenesis in adulthood, ageing and Alzheimer's disease.
    Nature. 2026 Feb 25. doi: 10.1038/s41586-026-10169.
    >> Share


    Neurobiol Aging

  48. ARGENTI L, Massa F, Losa M, Lombardo L, et al
    Neurotransmitter landscape and neurodegeneration patterns in Alzheimer's Disease.
    Neurobiol Aging. 2026;162:49-56.
    >> Share


    Neurochem Res

  49. MANOHARAN SD, Usman AS, Abdul Hamid H, Che Mohd Nassir CMN, et al
    Neuroprotective Mechanisms of Ficus deltoidea in an Alzheimer's Disease-Like Rat Model: Targeting Tau Hyperphosphorylation Through Glycogen Synthase Kinase-3 Beta and Protein Phosphatase 2A Regulation.
    Neurochem Res. 2026;51:81.
    >> Share


    Neuroscience

  50. PANDA SP, Saraswat N, Singh V
    Gene therapy targeting synaptopathy linked with Alzheimer's and Parkinson's disease.
    Neuroscience. 2026 Feb 21:S0306-4522(26)00138.
    >> Share


    Rev Neurol (Paris)

  51. BURRY E, Plumacker F, Villain N, Amaral S, et al
    Simulated shared and supported decision making for amyloid immunotherapy in Alzheimer's disease: A bicentric study.
    Rev Neurol (Paris). 2026 Feb 23:S0035-3787(26)00446.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016